- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06870630
Standard Versus Oesophago-gastric Junction Complex Myotomy for Treatment naïve Type 2 Achalasia Patients
June 9, 2025 updated by: Mohan Ramchandani, Asian Institute of Gastroenterology, India
- Consecutive eligible patients will be randomized in a 1:1 ratio to esophagogastric complex only myotomy or standard myotomy groups.
Randomization is done according to the computer-generated algorithm.
A clinical research coordinator will prepare the sealed randomization envelops and will hand over to the operating endoscopists before the beginning of the procedure.
Written informed consent will be obtained from all participants.
In this study, the participants and the care-provider assessing the clinical response to the POEM procedure at 3months will be blinded to the allocation.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
. Primary objective -
• To study the incidence of true reflux on 24 hour pH analysis with manual study.
Secondary objective -
- To analyse treatment success which is defined as Eckdart score < 3 at follow up assessment ( 3rd month)
- To analyse the recovery of peristalsis after POEM using High resolution manometry
- To study total procedure time , intra operative adverse effects and duration of hospital stay.
- Severity of oesophagitis
- Presence of GERD symptoms based on GERD questionnaire & Quality of life questionaire post procedure.
Study Type
Interventional
Enrollment (Estimated)
158
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Rajesh Dr Goud, M.Pharm, MBA
- Phone Number: 204 04023378888
- Email: rajeshgoud761@gmail.com
Study Contact Backup
- Name: Sreejith Dr OT, MBBS MD
- Phone Number: 500 04023378888
- Email: sreeju246@gmail.com
Study Locations
-
-
Telangana
-
Hyderabad, Telangana, India, 500082
- Recruiting
- Asian Institute of Gastroenterology /Aig Hospitals
-
Contact:
- ZAHEER DR NABI, MBBS MDDNB
- Phone Number: 04023378888
- Email: zaheernabi1978@gmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Adult >18 years
- Diagnosis of Type 2 Achalasia cardia based on High resolution manometry.
Exclusion Criteria:
- Patients with Type 1 & 3 ACHALASIA CARDIA
- Patients with previous endoscopic or surgical treatment for achalasia
- Patients with standard exclusion criteria for POEM procedure such as contraindication to general anesthesia, coagulopathy (international normalized ratio > 1.5, platelet count < 50 000/μL), portal hypertension, pregnancy, breast feeding women, and diffuse scarring in the esophagus due to previous surgery or radiation.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Per oral endoscopy myotomy for standard myotomy
Standard myotomy is muscle fibers cutting in esophagus more than 7 cms
|
Poem procedure is meant for cutting of circular and longitudinal muscle fibers in esophagus to reduce the symptoms of dysphagia, regurgitation and chestpain, weight loss.
|
|
Sham Comparator: Per oral endoscopy myotomy for esophago gastric junction myotomy
Myotomy is muscle fibers cutting in esophagus less than 3 cms.
|
Poem procedure is meant for cutting of circular and longitudinal muscle fibers in esophagus to reduce the symptoms of dysphagia, regurgitation and chestpain, weight loss.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incidence of true reflux based on 24-hour pH impedence
Time Frame: 3 months
|
Reflux parameters in percent are noted in impedence report like acidic and non acidic refluxes
|
3 months
|
|
Integrated Relaxation Pressure (IRP) at High resolution manometry test
Time Frame: 3 months
|
IRP in mm Hg measures pressure in the esophagus
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Mohan Dr Ramchandani, MBBS MD, AIG Hospitals
- Principal Investigator: Zaheer Dr Nabi, MBBS MD, AIG Hospitals
- Principal Investigator: Pradev Dr Inovolu, MBBS MD, AIG Hospitals
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 29, 2023
Primary Completion (Estimated)
June 14, 2025
Study Completion (Estimated)
July 30, 2025
Study Registration Dates
First Submitted
March 6, 2025
First Submitted That Met QC Criteria
March 6, 2025
First Posted (Actual)
March 11, 2025
Study Record Updates
Last Update Posted (Actual)
June 10, 2025
Last Update Submitted That Met QC Criteria
June 9, 2025
Last Verified
March 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- POEMUSM
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.